Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Kempapura, Murthy"'
Autor:
Feng Liu, F. Liaini Gross, Sneha Joshi, Manjusha Gaglani, Allison L. Naleway, Kempapura Murthy, Holly C. Groom, Meredith G. Wesley, Laura J. Edwards, Lauren Grant, Sara S. Kim, Suryaprakash Sambhara, Shivaprakash Gangappa, Terrence Tumpey, Mark G. Thompson, Alicia M. Fry, Brendan Flannery, Fatimah S. Dawood, Min Z. Levine
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Repeat vaccination with egg-based influenza vaccines could preferentially boost antibodies targeting the egg-adapted epitopes and reduce immunogenicity to circulating viruses. In this randomized trial (Clinicaltrials.gov: NCT03722589), sera
Externí odkaz:
https://doaj.org/article/449cb04fafee4863adbf535e92a66850
Autor:
Katherine Adams, John J. Riddles, Elizabeth A.K. Rowley, Shaun J. Grannis, Manjusha Gaglani, Bruce Fireman, Emily Hartmann, Allison L. Naleway, Edward Stenehjem, Alexandria Hughes, Alexandra F. Dalton, Karthik Natarajan, Kristin Dascomb, Chandni Raiyani, Stephanie A. Irving, Chantel Sloan-Aagard, Anupam B. Kharbanda, Malini B. DeSilva, Brian E. Dixon, Toan C. Ong, Jean Keller, Monica Dickerson, Nancy Grisel, Kempapura Murthy, Juan Nanez, William F. Fadel, Sarah W. Ball, Palak Patel, Julie Arndorfer, Mufaddal Mamawala, Nimish R. Valvi, Margaret M. Dunne, Eric P. Griggs, Peter J. Embi, Mark G. Thompson, Ruth Link-Gelles, Mark W. Tenforde
Publikováno v:
The Lancet Regional Health. Americas, Vol 23, Iss , Pp 100530- (2023)
Summary: Background: Understanding the usefulness of additional COVID-19 vaccine doses—particularly given varying disease incidence—is needed to support public health policy. We characterize the benefits of COVID-19 booster doses using number nee
Externí odkaz:
https://doaj.org/article/8acf40956eed4175ada422754f35470d
Autor:
Katherine Miller, Arnold Monto, H. Keipp Talbot, Manjusha Gaglani, Tresa McNeal, Fernanda Silveira, Richard Zimmerman, Donald Middleton, Shekhar Ghamande, Kempapura Murthy, Lindsay Kim, Jill Ferdinands, Manish Patel, Emily Martin
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2, Pp s62-s62 (2022)
Background: RSV is underrecognized in hospitalized adults. A better understanding of RSV in this population could help prioritize targeted viral-testing resources. Hospitalization and in-hospital outcomes are widely accepted as markers of clinical se
Externí odkaz:
https://doaj.org/article/46e9fb4677f7472fb87127fd55f10390
Autor:
Michael L. Jackson, Jill Ferdinands, Mary Patricia Nowalk, Richard K. Zimmerman, Burney Kieke, Manjusha Gaglani, Kempapura Murthy, Joshua G. Petrie, Emily T. Martin, Jessie R. Chung, Brendan Flannery, Lisa A. Jackson
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Routine influenza vaccine effectiveness (VE) surveillance networks use frequentist methods to estimate VE. With data from more than a decade of VE surveillance from diverse global populations now available, using Bayesian methods
Externí odkaz:
https://doaj.org/article/690eaeef3412436d9aa16d026d1f7d6d
Autor:
Mark W. Tenforde, Zachary A. Weber, Karthik Natarajan, Nicola P. Klein, Anupam B. Kharbanda, Edward Stenehjem, Peter J. Embi, Sarah E. Reese, Allison L. Naleway, Shaun J. Grannis, Malini B. DeSilva, Toan C. Ong, Manjusha Gaglani, Jungmi Han, Monica Dickerson, Bruce Fireman, Kristin Dascomb, Stephanie A. Irving, Gabriela Vazquez-Benitez, Suchitra Rao, Deepika Konatham, Palak Patel, Kristin E. Schrader, Ned Lewis, Nancy Grisel, Charlene McEvoy, Kempapura Murthy, Eric P. Griggs, Elizabeth A. K. Rowley, Ousseny Zerbo, Julie Arndorfer, Margaret M. Dunne, Kristin Goddard, Caitlin Ray, Yan Zhuang, Julius Timbol, Morgan Najdowski, Duck-Hye Yang, John Hansen, Sarah W. Ball, Ruth Link-Gelles
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1637-1646
During June-October 2022, the SARS-CoV-2 Omicron BA.5 sublineage accounted for most of the sequenced viral genomes in the United States, with further Omicron sublineage diversification through November 2022.* Bivalent mRNA vaccines contain an ancestr
Autor:
Alexandra F Dalton, Zachary A Weber, Katie S Allen, Edward Stenehjem, Stephanie A Irving, Talia L Spark, Katherine Adams, Ousseny Zerbo, Victoria Lazariu, Brian E Dixon, Kristin Dascomb, Emily Hartmann, Anupam B Kharbanda, Toan C Ong, Malini B DeSilva, Maura Beaton, Manjusha Gaglani, Palak Patel, Allison L Naleway, Magdalene N S Kish, Shaun J Grannis, Nancy Grisel, Chantel Sloan-Aagard, Suchitra Rao, Chandni Raiyani, Monica Dickerson, Elizabeth Bassett, William F Fadel, Julie Arndorfer, Juan Nanez, Michelle A Barron, Gabriela Vazquez-Benitez, I Chia Liao, Eric P Griggs, Sarah E Reese, Nimish R Valvi, Kempapura Murthy, Elizabeth A K Rowley, Peter J Embi, Sarah Ball, Ruth Link-Gelles, Mark W Tenforde
Publikováno v:
Clinical Infectious Diseases. 76:1615-1625
Background Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in communities with higher social vulnerability. Factors such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure risk and access to healthcare are
Autor:
Ruth Link-Gelles, Matthew E. Levy, Manjusha Gaglani, Stephanie A. Irving, Melissa Stockwell, Kristin Dascomb, Malini B. DeSilva, Sarah E. Reese, I-Chia Liao, Toan C. Ong, Shaun J. Grannis, Charlene McEvoy, Palak Patel, Nicola P. Klein, Emily Hartmann, Edward Stenehjem, Karthik Natarajan, Allison L. Naleway, Kempapura Murthy, Suchitra Rao, Brian E. Dixon, Anupam B. Kharbanda, Akintunde Akinseye, Monica Dickerson, Ned Lewis, Nancy Grisel, Jungmi Han, Michelle A. Barron, William F. Fadel, Margaret M. Dunne, Kristin Goddard, Julie Arndorfer, Deepika Konatham, Nimish R. Valvi, J. C. Currey, Bruce Fireman, Chandni Raiyani, Ousseny Zerbo, Chantel Sloan-Aagard, Sarah W. Ball, Mark G. Thompson, Mark W. Tenforde
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:931-939
The Omicron variant (B.1.1.529) of SARS-CoV-2, the virus that causes COVID-19, was first identified in the United States in November 2021, with the BA.1 sublineage (including BA.1.1) causing the largest surge in COVID-19 cases to date. Omicron sublin
Autor:
Jessie R. Chung, Sara S. Kim, Brendan Flannery, Michael E. Smith, Kayan Dunnigan, Chandni Raiyani, Kempapura Murthy, Manjusha Gaglani, Michael L. Jackson, Lisa A. Jackson, Todd Bear, Krissy Moehling Geffel, Mary Patricia Nowalk, Richard K. Zimmerman, Emily T. Martin, Lois Lamerato, Huong Q. McLean, Jennifer P. King, Edward A. Belongia, Mark G. Thompson, Manish Patel
Publikováno v:
Vaccine. 40:4322-4327
Influenza vaccines can mitigate illness severity, including reduced risk of ICU admission and death, in people with breakthrough infection. Less is known about vaccine attenuation of mild/moderate influenza illness. We compared subjective severity sc
Autor:
Allison L Naleway, Sara S Kim, Brendan Flannery, Min Z Levine, Kempapura Murthy, Suryaprakash Sambhara, Shivaprakash Gangappa, Laura J Edwards, Sarah Ball, Lauren Grant, Tnelda Zunie, Weiping Cao, F Liaini Gross, Holly Groom, Alicia M Fry, Danielle Hunt, Zuha Jeddy, Margarita Mishina, Meredith G Wesley, Sarah Spencer, Mark G Thompson, Manjusha Gaglani, Fatimah S Dawood
Publikováno v:
Open Forum Infectious Diseases.
Background Emerging data suggest second-generation influenza vaccines with higher hemagglutinin (HA) antigen content and/or different production methods may induce stronger antibody responses to HA than standard-dose egg-based influenza vaccines in a
Autor:
Nicola P. Klein, Maria Demarco, Katherine E. Fleming-Dutra, Melissa S. Stockwell, Anupam B. Kharbanda, Manjusha Gaglani, Suchitra Rao, Ned Lewis, Stephanie A. Irving, Emily Hartmann, Karthik Natarajan, Alexandra F. Dalton, Ousseny Zerbo, Malini B. DeSilva, Deepika Konatham, Edward Stenehjem, Elizabeth A. K. Rowley, Toan C. Ong, Shaun J. Grannis, Chantel Sloan-Aagard, Jungmi Han, Jennifer R Verani, Chandni Raiyani, Kristin Dascomb, Sarah E. Reese, Michelle A. Barron, William F. Fadel, Allison L. Naleway, Juan Nanez, Monica Dickerson, Kristin Goddard, Kempapura Murthy, Nancy Grisel, Zacharay A. Weber, Brian E. Dixon, Palak Patel, Bruce Fireman, Julie Arndorfer, Nimish R. Valvi, Eric P. Griggs, Carly Hallowell, Peter J. Embi, Sarah W. Ball, Mark G. Thompson, Mark W. Tenforde, Ruth Link-Gelles
Publikováno v:
Pediatrics. 151
OBJECTIVES We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the Omicron BA.4/BA.5 period. METHODS Using VISION Network records from April 2021